{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:53:44Z","timestamp":1792036424763,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Phenylketonuria (PKU) is a rare metabolic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine (Phe). Raised Phe levels can result in neurocognitive deficits, intellectual disabilities, and behavioral or psychiatric disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of review<\/jats:title>\n                    <jats:p>To conduct a systematic review of human studies on metabolites identified through metabolomics in individuals with PKU, compared to healthy controls, and to provide insights into their biological significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key scientific concepts of review<\/jats:title>\n                    <jats:p>A total of 26 human studies analyzing metabolites in urine and blood met the inclusion criteria. In total, 544 metabolites that differed between patients with PKU and healthy controls were identified through different metabolomic techniques (LC-MS, GC-MS, NMR). Differences were primarily observed in blood samples, which accounted for 95% of the total metabolites, with only 5% detected in urine samples, reflecting the limited use of this body fluid in only five studies. We found 60% of blood metabolites upregulated in patients with PKU, including Phe, Phe-related metabolites, lipids, and other amino acids, while tryptophan and kynurenine, among others, were downregulated (40%). Additionally, 35 metabolites (6% of the total) exhibited inconsistent directions of change (both up- and downregulated), including amino acids, carnitine derivatives, and lipids. These findings may be attributed to clinical factors (dietary adherence, supplementation, and treatment) and methodological differences in blood-derived matrices. Consequently, the high heterogeneity across studies, biological matrices and analytical platforms represents limitations for establishing a unique metabolomic signature. Overall, these results emphasize the metabolic complexity of PKU and highlight the potential of metabolomics to advance disease monitoring and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11306-026-02416-6","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:10:54Z","timestamp":1772896254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolomic profiling in phenylketonuria: a systematic review of human studies"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5057-5416","authenticated-orcid":false,"given":"Arnau","family":"Gonzalez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4064-5175","authenticated-orcid":false,"given":"Mireia","family":"Urpi-Sarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-5262","authenticated-orcid":false,"given":"Blanca","family":"Barrau-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2162-1756","authenticated-orcid":false,"given":"Francesc M.","family":"Campins-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadia","family":"Bakkali-Aissaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7810-1827","authenticated-orcid":false,"given":"Adriana","family":"Pan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5501-5272","authenticated-orcid":false,"given":"Pedro J.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-8905","authenticated-orcid":false,"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-4138","authenticated-orcid":false,"given":"Judit","family":"Garcia-Villoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-2467","authenticated-orcid":false,"given":"Aida","family":"Ormazabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-0250","authenticated-orcid":false,"given":"Dolores","family":"Garcia-Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6381-3063","authenticated-orcid":false,"given":"Carme","family":"Junqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-9933","authenticated-orcid":false,"given":"Gloria","family":"Garrabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-4445","authenticated-orcid":false,"given":"Rafael","family":"Llorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Consortium PKU.cat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"16","key":"2416_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163674","volume":"10","author":"F Andrade","year":"2021","unstructured":"Andrade, F., Cano, A., Unceta Suarez, M., Arza, A., Vinuesa, A., Ceberio, L., et al. (2021). Urine phenylacetylglutamine determination in patients with hyperphenylalaninemia. Journal of Clinical Medicine, 10(16), Article 3674. https:\/\/doi.org\/10.3390\/jcm10163674","journal-title":"Journal of Clinical Medicine"},{"key":"2416_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007392","author":"F Andrade","year":"2017","unstructured":"Andrade, F., L\u00f3pez-Su\u00e1rez, O., Llarena, M., Couce, M. L., & Ald\u00e1miz-Echevarri\u00e1, L. (2017). Influence of phenylketonuria\u2019s diet on dimethylated arginines and methylation cycle. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000007392","journal-title":"Medicine"},{"issue":"3","key":"2416_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clinbiochem.2003.10.017","volume":"37","author":"R Artuch","year":"2004","unstructured":"Artuch, R., Colom\u00e9, C., Sierra, C., Brandi, N., Lambruschini, N., Campistol, J., et al. (2004). A longitudinal study of antioxidant status in phenylketonuric patients. Clinical Biochemistry, 37(3), 198\u2013203. https:\/\/doi.org\/10.1016\/j.clinbiochem.2003.10.017","journal-title":"Clinical Biochemistry"},{"key":"2416_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/8904_2016_568","volume":"32","author":"H Blasco","year":"2017","unstructured":"Blasco, H., Veyrat-Durebex, C., Bertrand, M., Patin, F., Labarthe, F., Henique, H., et al. (2017). A multiplatform metabolomics approach to characterize plasma levels of phenylalanine and tyrosine in phenylketonuria. JIMD Reports, 32, 69\u201379. https:\/\/doi.org\/10.1007\/8904_2016_568","journal-title":"JIMD Reports"},{"issue":"9750","key":"2416_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau, N., Van Spronsen, F. J., & Levy, H. L. (2010). Phenylketonuria. Lancet, 376(9750), 1417\u20131427. https:\/\/doi.org\/10.1016\/S0140-6736(10)60961-0","journal-title":"Lancet"},{"key":"2416_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9120289","author":"R Bonte","year":"2019","unstructured":"Bonte, R., Bongaerts, M., Demirdas, S., Langendonk, J. G., Huidekoper, H. H., Williams, M., et al. (2019). Untargeted metabolomics-based screening method for inborn errors of metabolism using semi-automatic sample preparation with an UHPLC-orbitrap-MS platform. Metabolites. https:\/\/doi.org\/10.3390\/metabo9120289","journal-title":"Metabolites"},{"issue":"5","key":"2416_CR7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/jimd.12250","volume":"43","author":"L Boulet","year":"2020","unstructured":"Boulet, L., Besson, G., van Noolen, L., Faure, P., ECOPHEN Study Group, Maillot, F., & Corne, C. (2020). Tryptophan metabolism in phenylketonuria: A French adult cohort study. Journal of Inherited Metabolic Disease, 43(5), 944\u2013951. https:\/\/doi.org\/10.1002\/jimd.12250","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"2416_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1329-5","volume":"15","author":"C Cannet","year":"2020","unstructured":"Cannet, C., Pilotto, A., Rocha, J. C., Sch\u00e4fer, H., Spraul, M., Berg, D., et al. (2020). Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: Results of NMR metabolomics investigation. Orphanet Journal of Rare Diseases, 15(1), Article 61. https:\/\/doi.org\/10.1186\/s13023-020-1329-5","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"2416_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-021-01590-y","author":"J Carrard","year":"2022","unstructured":"Carrard, J., Guerini, C., Appenzeller-Herzog, C., Infanger, D., K\u00f6nigstein, K., Streese, L., et al. (2022). The metabolic signature of cardiorespiratory fitness: A systematic review. Sports Medicine. https:\/\/doi.org\/10.1007\/s40279-021-01590-y","journal-title":"Sports Medicine"},{"issue":"3","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","volume":"41","author":"KLM Coene","year":"2018","unstructured":"Coene, K. L. M., Kluijtmans, L. A. J., van der Heeft, E., Engelke, U. F. H., de Boer, S., Hoegen, B., et al. (2018). Next-generation metabolic screening: Targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients. Journal of Inherited Metabolic Disease, 41(3), 337\u2013353. https:\/\/doi.org\/10.1007\/s10545-017-0131-6","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"2416_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/jcbfm.2014.183","volume":"35","author":"MJ de Groot","year":"2015","unstructured":"de Groot, M. J., Sijens, P. E., Reijngoud, D. J., Paans, A. M., & van Spronsen, F. J. (2015). Phenylketonuria: Brain phenylalanine concentrations relate inversely to cerebral protein synthesis. Journal of Cerebral Blood Flow and Metabolism, 35(2), 200\u2013205. https:\/\/doi.org\/10.1038\/jcbfm.2014.183","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"2416_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.03.012","author":"SF Dobrowolski","year":"2022","unstructured":"Dobrowolski, S. F., Phua, Y. L., Vockley, J., Goetzman, E., & Blair, H. C. (2022). Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2022.03.012","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2013.04.017","volume":"109","author":"TD Douglas","year":"2013","unstructured":"Douglas, T. D., Jinnah, H. A., Bernhard, D., & Singh, R. H. (2013). The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. Molecular Genetics and Metabolism, 109(3), 243\u2013250. https:\/\/doi.org\/10.1016\/j.ymgme.2013.04.017","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18388\/abp.2018_2565","volume":"65","author":"S Drzyma\u0142a-Czy\u017c","year":"2018","unstructured":"Drzyma\u0142a-Czy\u017c, S., Ka\u0142uzny, \u0141, Krzyzanowska-Jankowska, P., Walkowiak, D., Mozrzymas, R., & Walkowiak, J. (2018). Deficiency of long-chain polyunsaturated fatty acids in phenylketonuria: A cross-sectional study. Acta Biochimica Polonica, 65(2), 303\u2013308. https:\/\/doi.org\/10.18388\/abp.2018_2565","journal-title":"Acta Biochimica Polonica"},{"key":"2416_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109044","author":"E Dybal","year":"2025","unstructured":"Dybal, E., Maillot, F., Feillet, F., Fouilhoux, A., Astudillo, L., Lavigne, C., et al. (2025). Bone mineral density in French adults with early-treated phenylketonuria. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109044","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"2416_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jhn.13015","volume":"35","author":"SJ Firman","year":"2022","unstructured":"Firman, S. J., Ramachandran, R., & Whelan, K. (2022). Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria. Journal of Human Nutrition and Dietetics, 35(6), 1016\u20131029. https:\/\/doi.org\/10.1111\/jhn.13015","journal-title":"Journal of Human Nutrition and Dietetics"},{"issue":"5","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejpn.2019.08.005","volume":"23","author":"R Gassi\u00f3","year":"2019","unstructured":"Gassi\u00f3, R., Gonz\u00e1lez, M. J., Sans, O., Artuch, R., Sierra, C., Ormazabal, A., et al. (2019). Prevalence of sleep disorders in early-treated phenylketonuric children and adolescents. Correlation with dopamine and serotonin status. European Journal of Paediatric Neurology, 23(5), 685\u2013691. https:\/\/doi.org\/10.1016\/j.ejpn.2019.08.005","journal-title":"European Journal of Paediatric Neurology"},{"issue":"5","key":"2416_CR18","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1021\/acs.jproteome.0c01052","volume":"20","author":"IMS Guerra","year":"2021","unstructured":"Guerra, I. M. S., Diogo, L., Pinho, M., Melo, T., Domingues, P., Domingues, M. R., & Moreira, A. S. P. (2021). Plasma phospholipidomic profile differs between children with phenylketonuria and healthy children. Journal of Proteome Research, 20(5), 2651\u20132661. https:\/\/doi.org\/10.1021\/acs.jproteome.0c01052","journal-title":"Journal of Proteome Research"},{"key":"2416_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108431","author":"IMS Guerra","year":"2020","unstructured":"Guerra, I. M. S., Ferreira, H. B., Neves, B., Melo, T., Diogo, L. M., Domingues, M. R., & Moreira, A. S. P. (2020). Lipids and phenylketonuria: Current evidences pointed the need for lipidomics studies. Archives of Biochemistry and Biophysics. https:\/\/doi.org\/10.1016\/j.abb.2020.108431","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"2416_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9010012","author":"HA Haijes","year":"2019","unstructured":"Haijes, H. A., Willemsen, M., van der Ham, M., Gerrits, J., Pras-Raves, M. L., Prinsen, H. C. M. T., et al. (2019). Direct infusion-based metabolomics identifies metabolic disease in patients\u2019 dried blood spots and plasma. Metabolites. https:\/\/doi.org\/10.3390\/metabo9010012","journal-title":"Metabolites"},{"issue":"3","key":"2416_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clinbiochem.2016.10.015","volume":"50","author":"MH Hampe","year":"2017","unstructured":"Hampe, M. H., Panaskar, S. N., Yadav, A. A., & Ingale, P. W. (2017). Gas chromatography\/mass spectrometry-based urine metabolome study in children for inborn errors of metabolism: An Indian experience. Clinical Biochemistry, 50(3), 121\u2013126. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.10.015","journal-title":"Clinical Biochemistry"},{"key":"2416_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00059","author":"L Hertz","year":"2013","unstructured":"Hertz, L. (2013). The glutamate-glutamine (GABA) cycle: Importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2013.00059","journal-title":"Frontiers in Endocrinology"},{"issue":"2","key":"2416_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","volume":"107","author":"A Hillert","year":"2020","unstructured":"Hillert, A., Anikster, Y., Belanger-Quintana, A., Burlina, A., Burton, B. K., Carducci, C., et al. (2020). The Genetic landscape and epidemiology of phenylketonuria. American Journal of Human Genetics, 107(2), 234\u2013250. https:\/\/doi.org\/10.1016\/j.ajhg.2020.06.006","journal-title":"American Journal of Human Genetics"},{"issue":"4","key":"2416_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jimd.12522","volume":"45","author":"B Hoegen","year":"2022","unstructured":"Hoegen, B., Hampstead, J. E., Engelke, U. F. H., Kulkarni, P., Wevers, R. A., Brunner, H. G., et al. (2022). Application of metabolite set enrichment analysis on untargeted metabolomics data prioritises relevant pathways and detects novel biomarkers for inherited metabolic disorders. Journal of Inherited Metabolic Disease, 45(4), 682\u2013695. https:\/\/doi.org\/10.1002\/jimd.12522","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"2416_CR25","doi-asserted-by":"publisher","unstructured":"Hollak, C. E. M., & Lachmann, R. (Eds.). (2016). Inherited Metabolic Disease in Adults: A Clinical Guide. Oxford Monographs on Medical Genetics. online edn, Oxford Academic, 1 Sept. 2016https:\/\/doi.org\/10.1093\/med\/9780199972135.001.0001","DOI":"10.1093\/med\/9780199972135.001.0001"},{"issue":"4","key":"2416_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41433-022-02019-0","volume":"37","author":"XW Hou","year":"2023","unstructured":"Hou, X. W., Wang, Y., Ke, C., & Pan, C. W. (2023). Metabolomics facilitates the discovery of metabolic profiles and pathways for myopia: A systematic review. Eye (London, England), 37(4), 670\u2013677. https:\/\/doi.org\/10.1038\/s41433-022-02019-0","journal-title":"Eye (London, England)"},{"key":"2416_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.aca.2018.03.058","volume":"1025","author":"M Jacob","year":"2018","unstructured":"Jacob, M., Malkawi, A., Albast, N., Al Bougha, S., Lopata, A., Dasouki, M., & Abdel Rahman, A. M. (2018). A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. Analytica Chimica Acta, 1025, 141\u2013153. https:\/\/doi.org\/10.1016\/j.aca.2018.03.058","journal-title":"Analytica Chimica Acta"},{"issue":"D1","key":"2416_CR28","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016). KEGG as a reference resource for gene and protein annotation. Nucleic Acids Research, 44(D1), D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070","journal-title":"Nucleic Acids Research"},{"key":"2416_CR29","doi-asserted-by":"publisher","unstructured":"Kong, S. W., & Hernandez-Ferrer, C. (2019). Assessment of coverage for endogenous metabolites and exogenous chemical compounds using an untargeted metabolomics platform. Biocomputing, 587\u2013598. https:\/\/doi.org\/10.1142\/9789811215636_0052","DOI":"10.1142\/9789811215636_0052"},{"key":"2416_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.689042","author":"N Li","year":"2021","unstructured":"Li, N., & Zhao, H. (2021). Role of carnitine in non-alcoholic fatty liver disease and other related diseases: An update. Frontiers in Medicine. https:\/\/doi.org\/10.3389\/fmed.2021.689042","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"2416_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23106","volume":"34","author":"L Liang","year":"2020","unstructured":"Liang, L., Ye, J., Han, L., Qiu, W., Zhang, H., Yu, Y., et al. (2020). Examining the blood amino acid status in pretherapeutic patients with hyperphenylalaninemia. Journal of Clinical Laboratory Analysis, 34(3), Article e23106. https:\/\/doi.org\/10.1002\/jcla.23106","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"16\u201317","key":"2416_CR32","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.clinbiochem.2008.06.018","volume":"41","author":"B Lumbreras","year":"2008","unstructured":"Lumbreras, B., Porta, M., M\u00e1rquez, S., Poll\u00e1n, M., Parker, L. A., & Hern\u00e1ndez-Aguado, I. (2008). QUADOMICS: An adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of \u2019-omics\u2019-based technologies. Clinical Biochemistry, 41(16\u201317), 1316\u20131325. https:\/\/doi.org\/10.1016\/j.clinbiochem.2008.06.018","journal-title":"Clinical Biochemistry"},{"key":"2416_CR33","doi-asserted-by":"publisher","unstructured":"MacDonald, A., Gokmen-Ozel, H., Van Rijn, M., & Burgard, P. (2010, December). The reality of dietary compliance in the management of phenylketonuria. Journal of Inherited Metabolic Disease. https:\/\/doi.org\/10.1007\/s10545-010-9073-y","DOI":"10.1007\/s10545-010-9073-y"},{"key":"2416_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01391-y","author":"A MacDonald","year":"2020","unstructured":"MacDonald, A., Van Wegberg, A. M. J., Ahring, K., Beblo, S., B\u00e9langer-Quintana, A., & Burlina, A. (2020). PKU dietary handbook to accompany PKU guidelines. Orphanet Journal of Rare Diseases. https:\/\/doi.org\/10.1186\/s13023-020-01391-y","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"6","key":"2416_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","volume":"38","author":"MJ Miller","year":"2015","unstructured":"Miller, M. J., Kennedy, A. D., Eckhart, A. D., Burrage, L. C., Wulff, J. E., Miller, L. A. D., et al. (2015). Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. Journal of Inherited Metabolic Disease, 38(6), 1029\u20131039. https:\/\/doi.org\/10.1007\/s10545-015-9843-7","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"2416_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041195","author":"D Mordaunt","year":"2020","unstructured":"Mordaunt, D., Cox, D., & Fuller, M. (2020). Metabolomics to improve the diagnostic efficiency of inborn errors of metabolism. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21041195","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"2416_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107509","volume":"138","author":"L Moritz","year":"2023","unstructured":"Moritz, L., Klotz, K., Gr\u00fcnert, S. C., Hannibal, L., & Spiekerkoetter, U. (2023). Metabolic phenotyping in phenylketonuria reveals disease clustering independently of metabolic control. Molecular Genetics and Metabolism, 138(3), Article 107509. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107509","journal-title":"Molecular Genetics and Metabolism"},{"issue":"8","key":"2416_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043021","volume":"7","author":"U M\u00fctze","year":"2012","unstructured":"M\u00fctze, U., Beblo, S., Kortz, L., Matthies, C., Koletzko, B., Bruegel, M., et al. (2012). Metabolomics of dietary fatty acid restriction in patients with phenylketonuria. PLoS ONE, 7(8), Article e43021. https:\/\/doi.org\/10.1371\/journal.pone.0043021","journal-title":"PLoS ONE"},{"key":"2416_CR39","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J., Moher, D., Bossuyt, P. M., et al. (2021). PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. Bmj, 372, n160. https:\/\/doi.org\/10.1136\/bmj.n160(n.d.).","journal-title":"Bmj"},{"issue":"2","key":"2416_CR40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00216-006-0546-7","volume":"387","author":"Z Pan","year":"2007","unstructured":"Pan, Z., Gu, H., Talaty, N., Chen, H., Shanaiah, N., Hainline, B. E., et al. (2007). Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Analytical and Bioanalytical Chemistry, 387(2), 539\u2013549. https:\/\/doi.org\/10.1007\/s00216-006-0546-7","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"W1","key":"2416_CR41","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z., Lu, Y., Zhou, G., Hui, F., Xu, L., Viau, C., et al. (2024). MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Research, 52(W1), W398\u2013W406. https:\/\/doi.org\/10.1093\/nar\/gkae253","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"2416_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011419","volume":"5","author":"LA Parker","year":"2010","unstructured":"Parker, L. A., Saez, N. G., Lumbreras, B., Porta, M., & Hern\u00e1ndez-Aguado, I. (2010). Methodological deficits in diagnostic research using \u201c-Omics\u201d technologies: Evaluation of the QUADOMICS tool and quality of recently published studies. PLoS ONE, 5(7), Article e11419. https:\/\/doi.org\/10.1371\/journal.pone.0011419","journal-title":"PLoS ONE"},{"issue":"14","key":"2416_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1056\/NEJM197004022821401","volume":"282","author":"TL Perry","year":"1970","unstructured":"Perry, T. L., Hansen, S., Tischler, B., Bunting, R., & Diamond, S. (1970). Glutamine depletion in phenylketonuria. The New England Journal of Medicine, 282(14), 761\u2013766. https:\/\/doi.org\/10.1056\/NEJM197004022821401","journal-title":"The New England Journal of Medicine"},{"key":"2416_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-018-0202-x","author":"D Rausell","year":"2019","unstructured":"Rausell, D., Garc\u00eda-Blanco, A., Correcher, P., Vitoria, I., Vento, M., & Ch\u00e1fer-Peric\u00e1s, C. (2019). Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients. Pediatric Research. https:\/\/doi.org\/10.1038\/s41390-018-0202-x","journal-title":"Pediatric Research"},{"issue":"5","key":"2416_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10571-011-9693-2","volume":"31","author":"GS Ribas","year":"2011","unstructured":"Ribas, G. S., Sitta, A., Wajner, M., & Vargas, C. R. (2011). Oxidative stress in phenylketonuria: What is the evidence? Cellular and Molecular Neurobiology, 31(5), 653\u2013662. https:\/\/doi.org\/10.1007\/s10571-011-9693-2","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"5","key":"2416_CR46","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.clnu.2023.03.007","volume":"42","author":"M Rondanelli","year":"2023","unstructured":"Rondanelli, M., Porta, F., Gasparri, C., Barrile, G. C., Cavioni, A., Mansueto, F., et al. (2023). A food pyramid for adult patients with phenylketonuria and a systematic review on the current evidences regarding the optimal dietary treatment of adult patients with PKU. Clinical Nutrition, 42(5), 732\u2013763. https:\/\/doi.org\/10.1016\/j.clnu.2023.03.007","journal-title":"Clinical Nutrition"},{"issue":"3","key":"2416_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ymgme.2011.03.019","volume":"103","author":"Y Sanayama","year":"2011","unstructured":"Sanayama, Y., Nagasaka, H., Takayanagi, M., Ohura, T., Sakamoto, O., Ito, T., et al. (2011). Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Molecular Genetics and Metabolism, 103(3), 220\u2013225. https:\/\/doi.org\/10.1016\/j.ymgme.2011.03.019","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"2416_CR48","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/BF00712012","volume":"17","author":"P Sanjurjo","year":"1994","unstructured":"Sanjurjo, P., Perteagudo, L., Soriano, J. R., Vilaseca, A., & Campistol, J. (1994). Polyunsaturated fatty acid status in patients with phenylketonuria. Journal of Inherited Metabolic Disease, 17(6), 704\u2013709.","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"3","key":"2416_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/ajcn\/nqab400","volume":"115","author":"MS Schoen","year":"2022","unstructured":"Schoen, M. S., & Singh, R. H. (2022). Plasma metabolomic profile changes in females with phenylketonuria following a camp intervention. American Journal of Clinical Nutrition, 115(3), 811\u2013821. https:\/\/doi.org\/10.1093\/ajcn\/nqab400","journal-title":"American Journal of Clinical Nutrition"},{"issue":"19","key":"2416_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194056","volume":"14","author":"MS Schoen","year":"2022","unstructured":"Schoen, M. S., Ramakrishnan, U., Alvarez, J. A., Ziegler, T. R., Cui, X., & Singh, R. H. (2022). Characterization of choline nutriture among adults and children with phenylketonuria. Nutrients, 14(19), Article 4056. https:\/\/doi.org\/10.3390\/nu14194056","journal-title":"Nutrients"},{"key":"2416_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-08894-5_2","author":"A Schousboe","year":"2014","unstructured":"Schousboe, A., Scafidi, S., Bak, L. K., Waagepetersen, H. S., & McKenna, M. C. (2014). Glutamate metabolism in the brain focusing on astrocytes. Advances in Neurobiology. https:\/\/doi.org\/10.1007\/978-3-319-08894-5_2","journal-title":"Advances in Neurobiology"},{"issue":"10","key":"2416_CR52","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/CLINCHEM\/48.10.1794","volume":"48","author":"KH Schulpis","year":"2002","unstructured":"Schulpis, K. H., Karikas, G. A., Tjamouranis, J., Michelakakis, H., & Tsakiris, S. (2002). Acetylcholinesterase activity and biogenic amines in phenylketonuria. Clinical Chemistry, 48(10), 1794\u20131796. https:\/\/doi.org\/10.1093\/CLINCHEM\/48.10.1794","journal-title":"Clinical Chemistry"},{"issue":"1","key":"2416_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","volume":"1740","author":"LR Sirtori","year":"2005","unstructured":"Sirtori, L. R., Dutra-Filho, C. S., Fitarelli, D., Sitta, A., Haeser, A., Barschak, A. G., et al. (2005). Oxidative stress in patients with phenylketonuria. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1740(1), 68\u201373. https:\/\/doi.org\/10.1016\/j.bbadis.2005.02.005","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"2","key":"2416_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10571-008-9313-y","volume":"29","author":"A Sitta","year":"2009","unstructured":"Sitta, A., Barschak, A. G., Deon, M., De Mari, J. F., Barden, A. T., Vanzin, C. S., et al. (2009). L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cellular and Molecular Neurobiology, 29(2), 211\u2013218. https:\/\/doi.org\/10.1007\/s10571-008-9313-y","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"2","key":"2416_CR55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jn\/nxx039","volume":"148","author":"BM Stroup","year":"2018","unstructured":"Stroup, B. M., Nair, N., Murali, S. G., Broniowska, K., Rohr, F., Levy, H. L., & Ney, D. M. (2018). Metabolomic markers of essential fatty acids, carnitine, and cholesterol metabolism in adults and adolescents with phenylketonuria. The Journal of Nutrition, 148(2), 194\u2013201. https:\/\/doi.org\/10.1093\/jn\/nxx039","journal-title":"The Journal of Nutrition"},{"key":"2416_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201800384","author":"MM Ulaszewska","year":"2019","unstructured":"Ulaszewska, M. M., Weinert, C. H., Trimigno, A., Portmann, R., Andres Lacueva, C., & Badertscher, R. (2019). Nutrimetabolomics: An integrative action for metabolomic analyses in human nutritional studies. Molecular Nutrition & Food Research. https:\/\/doi.org\/10.1002\/mnfr.201800384","journal-title":"Molecular Nutrition & Food Research"},{"issue":"3","key":"2416_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10545-017-0109-4","volume":"41","author":"J V\u00e1clav\u00edk","year":"2018","unstructured":"V\u00e1clav\u00edk, J., Coene, K. L. M., Vrobel, I., Najdekr, L., Friedeck\u00fd, D., Karl\u00edkov\u00e1, R., et al. (2018). Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra. Journal of Inherited Metabolic Disease, 41(3), 407\u2013414. https:\/\/doi.org\/10.1007\/s10545-017-0109-4","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"2416_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00267-0","author":"FJ van Spronsen","year":"2021","unstructured":"van Spronsen, F. J., Blau, N., Harding, C., Burlina, A., Longo, N., & Bosch, A. M. (2021). Phenylketonuria. Nature Reviews Disease Primers. https:\/\/doi.org\/10.1038\/s41572-021-00267-0","journal-title":"Nature Reviews Disease Primers"},{"key":"2416_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109125","author":"AMJ van Wegberg","year":"2025","unstructured":"van Wegberg, A. M. J., MacDonald, A., Ahring, K., B\u00e9langer-Quintana, A., Beblo, S., & Blau, N. (2025). European guidelines on diagnosis and treatment of phenylketonuria: First revision. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109125","journal-title":"Molecular Genetics and Metabolism"},{"key":"2416_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0685-2","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg, A. M. J., MacDonald, A., Ahring, K., B\u00e9langer-Quintana, A., Blau, N., & Bosch, A. M. (2017). The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet Journal of Rare Diseases. https:\/\/doi.org\/10.1186\/s13023-017-0685-2","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"2416_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00711322","volume":"16","author":"MA Vilaseca","year":"1993","unstructured":"Vilaseca, M. A., Briones, P., Ferrer, I., Campistol, J., Riverola, A., Castillo, P., & Ramon, F. (1993). Controlled diet in phenylketonuria may cause serum carnitine deficiency. Journal of Inherited Metabolic Disease, 16(1), 101\u2013104. https:\/\/doi.org\/10.1007\/BF00711322","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"4\u20135","key":"2416_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.clinbiochem.2009.11.013","volume":"43","author":"MA Vilaseca","year":"2010","unstructured":"Vilaseca, M. A., Lambruschini, N., G\u00f3mez-L\u00f3pez, L., Guti\u00e9rrez, A., Moreno, J., Tondo, M., et al. (2010). Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin. Clinical Biochemistry, 43(4\u20135), 411\u2013415. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.11.013","journal-title":"Clinical Biochemistry"},{"issue":"3","key":"2416_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/15513815.2020.1846647","volume":"41","author":"Z Wan","year":"2022","unstructured":"Wan, Z., Rosenbaum, E. R., Liu, W., Song, B., Yue, X., Kong, Y., et al. (2022). Benchmark examination of blood amino acids patterns in phenylketonuria neonates and young children on phenylalanine-restricted dietary treatment. Fetal and Pediatric Pathology, 41(3), 443\u2013450. https:\/\/doi.org\/10.1080\/15513815.2020.1846647","journal-title":"Fetal and Pediatric Pathology"},{"issue":"2","key":"2416_CR64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000165356","volume":"53","author":"C Weigel","year":"2008","unstructured":"Weigel, C., Kiener, C., Meier, N., Schmid, P., Rauh, M., Rascher, W., & Knerr, I. (2008). Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets. Annals of Nutrition and Metabolism, 53(2), 91\u201395. https:\/\/doi.org\/10.1159\/000165356","journal-title":"Annals of Nutrition and Metabolism"},{"key":"2416_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting, P., Rutjes, A. W. S., Reitsma, J. B., Bossuyt, P. M. M., & Kleijnen, J. (2003). The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology, 3, Article 25. https:\/\/doi.org\/10.1186\/1471-2288-3-25","journal-title":"BMC Medical Research Methodology"},{"issue":"22","key":"2416_CR66","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1039\/c9an01642b","volume":"144","author":"J Wild","year":"2019","unstructured":"Wild, J., Shanmuganathan, M., Hayashi, M., Potter, M., & Britz-Mckibbin, P. (2019). Metabolomics for improved treatment monitoring of phenylketonuria: Urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies. Analyst, 144(22), 6595\u20136608. https:\/\/doi.org\/10.1039\/c9an01642b","journal-title":"Analyst"},{"issue":"D1","key":"2416_CR67","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., et al. (2022). HMDB 5.0: The Human Metabolome Database for 2022. Nucleic Acids Research, 50(D1), D622\u2013D631. https:\/\/doi.org\/10.1093\/nar\/gkab1062","journal-title":"Nucleic Acids Research"},{"issue":"29","key":"2416_CR68","doi-asserted-by":"publisher","first-page":"8825","DOI":"10.1007\/s00216-015-9041-3","volume":"407","author":"X Xiong","year":"2015","unstructured":"Xiong, X., Sheng, X., Liu, D., Zeng, T., Peng, Y., & Wang, Y. (2015). A GC\/MS-based metabolomic approach for reliable diagnosis of phenylketonuria. Analytical and Bioanalytical Chemistry, 407(29), 8825\u20138833. https:\/\/doi.org\/10.1007\/s00216-015-9041-3","journal-title":"Analytical and Bioanalytical Chemistry"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02416-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:21:01Z","timestamp":1778102461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02416-6","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"39"}}